Risk of iron overload in carriers of genetic mutations associated with hereditary haemochromatosis: UK Food Standards Agency workshop

British Journal of Nutrition

Volumn 96, Issue 4, 2006, Pages 770-773

  Singh, Mamta ^a   Ashwell, Margaret ^b   Sanderson, Peter ^a   Cade, Janet ^c   Moreton, Jennifer ^c   Fairweather Tait, Susan ^d   Roe, Mark ^d   Marx, Joannes J M ^e   Worwood, Mark ^f   Cook, James D ^g  

^a FOOD STANDARDS AGENCY   (United Kingdom)

^b Ashwell Associates   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f CARDIFF UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Food Standards Agency workshops; Hereditary haemochromatosis; Iron overload

Indexed keywords

HFE PROTEIN; IRON; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ATHEROSCLEROSIS; CONFERENCE PAPER; DIETARY INTAKE; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE; HUMAN; IRON ABSORPTION; IRON METABOLISM; IRON OVERLOAD; MORBIDITY; MORTALITY; RISK ASSESSMENT; UNITED KINGDOM; WORKSHOP; CONSENSUS DEVELOPMENT; DIET; GENETIC PREDISPOSITION; GENETICS; IRON INTAKE; MUTATION;

ATHEROSCLEROSIS; DIET; GENETIC PREDISPOSITION TO DISEASE; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON OVERLOAD; IRON, DIETARY; MEMBRANE PROTEINS; MUTATION;

EID: 33947493323     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1079/BJN20061892     Document Type: Conference Paper

References (40)

1. Beutler E, Felitti VJ, Koziol JA, Ho NJ & Gelbart T (2002) Penetrance of 845G → A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359, 211-218.
2. Bothwell TH & MacPhail AP (1998) Hereditary hemochromatosis: Etiologic, pathologic, and clinical aspects. Semin Hematol 35, 55-71.
3. Cade JE, Moreton JA, O'Hara B, Greenwood DC, Moor J, Burley VJ, Kukalizch K, Bishop DT & Worwood M (2005) Diet and genetic factors associated with iron status in middle-aged women. Am J Clin Nutr 82, 813-820.
4. Cook JD, Flowers CH & Skikne BS (2003) The quantitative assessment of body iron. Blood 101, 3359-3364.
5. Coppin H, Bensaid M, Fruchon S, Borot N, Blanche H & Roth MP (2003) Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: Case control study of 492 French centenarians. BMJ 327, 132-133.
6. Danesh J & Appleby P (1999) Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 99, 852-854.
7. Danesh J, Collins R, Appleby P & Peto R (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 279, 1477-1482.
8. de Valk B, Addicks MA, Gosriwatana I, Lu S, Hider RC & Marx JJ (2000) Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest 30, 248-251.
9. Ellervik C, Tybjaerg-Hansen A, Grande P, Appleyard M & Nordestgaard BG (2005) Hereditary hemochromatosis and risk of ischemic heart disease: A prospective study and a case-control study. Circulation 112, 185-193.
10. Feder JN, Gnirke A, Thomas W, et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13, 399-408.
11. Greenwood DC, Cade JE, Moreton JA, O'Hara B, Burley VJ, Randerson-Moor JA, Kukalizch K, Thompson D, Worwood M & Bishop DT (2005) HFE genotype modifies the influence of heme iron intake on iron status. Epidemiology 16, 802-805.
12. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A & Sadler PJ (1989) Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem 264, 4417-4422.
13. Gunn IR, Maxwell FK, Gaffney D, McMahon AD & Packard CJ (2004) Haemochromatosis gene mutations and risk of coronary heart disease: A west of Scotland coronary prevention study (WOSCOPS) substudy. Heart 90, 304-306.
14. Hunt JR & Zeng H (2004) Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis. Am J Clin Nutr 80, 924-931.
15. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA & Worwood M (2001) HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 114, 474-484.
16. Kartikasari AE, Georgiou NA, Visseren FL, Kats-Renaud H, van Asbeck BS & Marx JJM (2004) Intracellular labile iron modulates adhesion of human monocytes to human endothelial cells. Arterioscler Thromb Vasc Biol 24, 2257-2262.
17. Kemna E, Tjalsma H, Laarakkers C, Nemeth E, Willems H & Swinkels D (2005) Novel urine hepcidin assay by mass spectrometry. Blood 106, 3268-3270.
18. Kiechl S, Willeit J, Egger G, Poewe W & Oberhollenzer F (1997) Body iron stores and the risk of carotid atherosclerosis: Prospective results from the Bruneck Study. Circulation 96, 3300-3307.
19. Knuiman MW, Divitini ML, Olynyk JK, Cullen DJ & Bartholomew HC (2003) Serum ferritin and cardiovascular disease: A 17-year follow-up study in Busselton, Western Australia. Am J Epidemiol 158, 144-149.
20. Kooistra MP, Kersting S, Gosriwatana I, Lu S, Nijhoff-Schutte J, Hider RC & Marx JJ (2002) Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion. Eur J Clin Invest 32, Suppl. 1, 36-41.
21. Lynch SR, Skikne BS & Cook JD (1989) Food iron absorption in idiopathic hemochromatosis. Blood 74, 2187-2193.
22. McCune CA, AI Jader LN, May A, Hayes SL, Jackson HA & Worwood M (2002) Hereditary haemochromatosis: Only 1 % of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload. Hum Genet 111, 538-543.
23. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J & Robson KJ (2000) Geography of HFE C282Y and H63D mutations. Genet Test 4, 183-198.
24. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T & Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093.
25. Rasmussen ML, Folsom AR, Catellier DJ, Tsai MY, Garg U & Eckfeldt JH (2001) A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis 154, 739-746.
26. Reunanen A, Takkunen H, Knekt P, Seppanen R & Aromaa A (1995) Body iron stores, dietary iron intake and coronary heart disease mortality. J Intern Med 238, 223-230.
27. Roe MA, Heath AL, Oyston SL, Macrow C, Hoogewerff JA, Foxall R, Dainty JR, Majsak-Newman G, Willis G & Fairweather-Tait SJ (2005) Iron absorption in male C282Y heterozygotes. Am J Clin Nutr 81, 814-821.
28. Roest M, van der Schouw YT, de Valk B, Marx JJ, Tempelman MJ, de Groot PG, Sixma JJ & Banga JD (1999) Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation 100, 1268-1273.
29. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D & Camaschella C (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33, 21-22.
30. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R & Salonen R (1992) High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86, 803-811.
31. Sempos CT, Looker AC, Gillum RF & Makuc DM (1994) Body iron stores and the risk of coronary heart disease. N Engl J Med 330, 1119-1124.
32. Sullivan JL (1981) Iron and the sex difference in heart disease risk. Lancet 1, 1293-1294.
33. Swinkels DW, Janssen MC, Bergmans J & Marx JJM (2006) Hereditary hemochromatosis: Genetic complexity and new diagnostic approaches. Clin Chem 52, 950-968.
34. The UK Haemochromatosis Consortium (1997) A simple genetic test identifies 90 % of UK patients with haemochromatosis. Gut 41, 841-844.
35. Tuomainen TP, Kontula K, Nyyssonen K, Lakka TA, Helio T & Salonen JT (1999) Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: A prospective cohort study in men in eastern Finland. Circulation 100, 1274-1279.
36. Tuomainen TP, Punnonen K, Nyyssonen K & Salonen JT (1998) Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 97, 1461-1466.
37. van der A DL, Grobbee DE, Roest M, Marx JJM, Voorbij HA & van der Schouw YT (2005) Serum ferritin is a risk factor for stroke in postmenopausal women. Stroke 36, 1637-1641.
38. van der A DL, Marx JJM, Grobbee DE, Kamphuis MH, Georgiou NA, van kats-Renaud JH, Breuer W, Cabantchik ZI, Roest M & Voorbij HA (2006) Non-transferrin-bound iron and risk of coronary heart disease in postmenopausal women. Circulation 113, 1942-1949.
39. Willis G, Wimperis JZ, Smith KC, Fellows IW & Jennings BA (1999) Haemochromatosis gene C282Y homozygotes in an elderly male population. Lancet 354, 221-222.
40. Wolff B, Volzke H, Ludemann J, Robinson D, Vogelgesang D, Staudt A, Kessler C, Dahm JB, John U & Felix SB (2004) Association between high serum ferritin levels and carotid atherosclerosis in the Study of Health in Pomerania (SHIP). Stroke 35, 453-457.